SCHEMBL11296532

SCHEMBL11296532

COC(=O)c1ccc(N(c2cccc(Cl)c2)C2CCNC2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 3/20 0.40
▸ OPRM1 P35372 1/20 0.39
▸ OPRD1 P41143 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ MAPK14 Q16539 2/20 0.38
▸ MAPT P10636 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ GRM5 P41594 2/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ GHSR Q92847 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MAP2K4 P45985 1/20 0.35
▸ TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11295039 0.89 PSEN1 (0.40) SLC6A3GAATSHRKCNH2KMT2A
SCHEMBL11296058 0.88 MEN1 (0.47) OPRM1OPRD1OPRK1MAPTGAA
SCHEMBL11298752 0.86 HDAC8 (0.42) GRM5
SCHEMBL11299441 0.85 MAPK14 (0.37) SLC6A3OPRM1OPRD1OPRK1MAPK14
SCHEMBL11296615 0.84 FLT1 (0.38) SLC6A3MAPK14MAPTKCNH2MEN1
SCHEMBL11301393 0.81 ALOX15 (0.56) OPRD1MAPTGAAMEN1KMT2A
SCHEMBL11296506 0.80 ALOX15 (0.44) TSHRALDH1A1KDM4ERAB9AL3MBTL1
SCHEMBL11297424 0.77 HDAC1 (0.43) OPRM1OPRD1OPRK1MAPTALDH1A1
SCHEMBL11299470 0.77 PARP1 (0.33) GAAGHSRALDH1A1TACR1L3MBTL1
SCHEMBL11304382 0.76 HDAC8 (0.38) MAPK1GRM5ALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback